EA202191818A1 - 3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOL COMPOUNDS WITH INHIBITING ACTIVITY AGAINST CDK2 - Google Patents
3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOL COMPOUNDS WITH INHIBITING ACTIVITY AGAINST CDK2Info
- Publication number
- EA202191818A1 EA202191818A1 EA202191818A EA202191818A EA202191818A1 EA 202191818 A1 EA202191818 A1 EA 202191818A1 EA 202191818 A EA202191818 A EA 202191818A EA 202191818 A EA202191818 A EA 202191818A EA 202191818 A1 EA202191818 A1 EA 202191818A1
- Authority
- EA
- Eurasian Patent Office
- Prior art keywords
- carbonylamino
- cyclopentyl
- compounds
- activity against
- inhibiting activity
- Prior art date
Links
Abstract
Изобретение относится к соединениям формулы (I)и их энантиомерам, и к фармацевтически приемлемым солям формулы (I) и указанных энантиомеров, где R1, R2 и R3 такие, как определено в данном документе. Изобретение также относится к фармацевтическим композициям, содержащим такие соединения и соли, и к способам и применениям таких соединений, солей и композиций для лечения аномального роста клеток, включая рак, у нуждающегося в этом субъекта.The invention relates to compounds of formula (I) and their enantiomers, and to pharmaceutically acceptable salts of formula (I) and said enantiomers, where R1, R2 and R3 are as defined herein. The invention also relates to pharmaceutical compositions containing such compounds and salts, and to methods and uses of such compounds, salts and compositions for the treatment of abnormal cell growth, including cancer, in a subject in need thereof.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062959042P | 2020-01-09 | 2020-01-09 | |
| PCT/IB2020/050653 WO2020157652A2 (en) | 2019-01-31 | 2020-01-28 | Cdk2 inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EA202191818A1 true EA202191818A1 (en) | 2021-10-20 |
Family
ID=78572593
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EA202191818A EA202191818A1 (en) | 2020-01-09 | 2020-01-28 | 3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOL COMPOUNDS WITH INHIBITING ACTIVITY AGAINST CDK2 |
Country Status (2)
| Country | Link |
|---|---|
| EA (1) | EA202191818A1 (en) |
| GE (1) | GEP20227451B (en) |
-
2020
- 2020-01-28 GE GEAP202015709A patent/GEP20227451B/en unknown
- 2020-01-28 EA EA202191818A patent/EA202191818A1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| GEP20227451B (en) | 2022-12-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2021009276A (en) | 3-carbonylamino-5-cyclopentyl-1 fi-pyrazole compounds having inhibitory activity on cdk2. | |
| MX2021016085A (en) | Benzisoxazole sulfonamide derivatives. | |
| PH12019500329A1 (en) | Pyridopyrimdinone cdk2/4/6 inhibitors | |
| EA200971104A1 (en) | Derivatives of benzimidazole | |
| EA201490673A1 (en) | DERIVATIVES OF PYRROLOPYRIMIDINE AND PURIN | |
| EA201892300A1 (en) | MCL1 MACROCYCLIC INHIBITORS FOR CANCER TREATMENT | |
| MX2023007192A (en) | Prmts inhibitors. | |
| EA200801287A1 (en) | Pyrimidine derivatives for the treatment of anomalous cell growth | |
| EA201201161A1 (en) | PYRROPYRIMIDINES AS CDK4 / 6 INHIBITORS | |
| GEP20227434B (en) | 2,3-dihydro-1h-pyrrolo[3,4-c]pyridin-1-one derivatives as hpk1 inhibitors for the treatment of cancer | |
| EA200701808A1 (en) | Derivatives of tetrahydroindolone and tetrahydroindazole | |
| EA201590879A1 (en) | ARYL-CONDENSED AND HETEROARYL-CONDENSED LACTAMS | |
| EA201201159A1 (en) | DETERATED PYRROPOLYMIDININE COMPOUNDS AS CDK4 / 6 INHIBITORS | |
| EA200901250A1 (en) | SULPHONYLAMID DERIVATIVES FOR THE TREATMENT OF ANOMALOUS GROWTH OF CELLS | |
| MX2022013401A (en) | Azalactam compounds as hpk1 inhibitors. | |
| BR112021017620A2 (en) | Macrocyclic compounds | |
| EA200601796A1 (en) | Pyrimidine derivatives for the treatment of anomalous cell growth | |
| EA201101533A1 (en) | HETEROCYCLIC COMPOUNDS AS MEK INHIBITORS | |
| EA201400831A1 (en) | Pyrazolopyrimidinyl inhibitors of ubiquitin-activating enzyme | |
| CR20230604A (en) | Her2 mutation inhibitors | |
| CL2023001367A1 (en) | btk inhibitors | |
| EA201650003A1 (en) | CYCLOALCYL-DIGETERO-CYCLIC DERIVATIVES | |
| EA202191818A1 (en) | 3-CARBONYLAMINO-5-CYCLOPENTYL-1H-PYRAZOL COMPOUNDS WITH INHIBITING ACTIVITY AGAINST CDK2 | |
| EA201992528A1 (en) | METHODS OF APPLICATION OF TRIZOSMITTED DERIVATIVES OF BENZOTRIAZOLE AS DIGYDROOROTATOXYGENASE INHIBITORS | |
| EA201990196A1 (en) | Pyridopyrimidinone Inhibitors CDK2 / 4/6 |